Legionella Testing Market Forecast to Expand at 8.7% CAGR Through 2032

Key Highlights

The Legionella Testing Market was valued at USD 371.73 Million in 2025 and is expected to reach nearly USD 666.56 Million by 2032, growing at a CAGR of 8.7% from 2026 to 2032.

Microbial culture was the dominant test-type segment in 2025, while polymerase chain reaction, or PCR, is the rapidly growing segment. North America led regionally. Asia Pacific held about 20% share in 2025 and is the fastest-growing region at an 8.7% CAGR.

Why This Matters Now

The Legionella Testing Market is moving from a specialist laboratory requirement toward a broader public-health and healthcare-infrastructure priority. The worldwide incidence of community-acquired pneumonia ranges from approximately 1.5 to 14 cases per 1,000 people each year, while an ageing population increases susceptibility to respiratory infections including Legionnaires’ disease, Pontiac fever and pneumonia.

Get Exclusive Sample Access: https://www.maximizemarketresearch.com/request-sample/228914/

Legionellosis can resemble pneumonia and severe cases may require hospitalisation. Ageing infrastructure, moisture, urbanisation and complex water networks also strengthen the case for regular monitoring.

Market Overview

The Legionella Testing Market is projected to rise from USD 371.73 Million in 2025 to nearly USD 666.56 Million by 2032 at an 8.7% CAGR. The commercial opportunity spans culture media, urine antigen testing, PCR, serology and direct fluorescent antibody testing, alongside water, biofilm, swab, respiratory, urine and blood samples.

Technologies include real-time PCR, multiplex PCR, loop-mediated isothermal amplification, next-generation sequencing and immunoassay-based testing. Applications cover water testing and IVD, with hospitals, clinics, environmental testing providers, diagnostic laboratories and water-treatment industries among end users.

Growth Trends

Technology is changing the Legionella Testing Market by shortening the path from sample collection to intervention. MMR identifies PCR, rapid antigen tests, lateral-flow immunoassays, biosensors and automation among technologies reshaping testing. Point-of-care solutions and digital platforms also improve data management and process efficiency.

Faster results support timely intervention and outbreak response. More user-friendly methods can broaden access beyond laboratories with long-established culture workflows. Alliances between water-treatment companies and diagnostic laboratories are also strengthening supply chains.

Segment Insights

In the Legionella Testing Market, microbial culture held the largest test-type share in 2025 and remains the dominant segment. Laboratories use culture media to cultivate and isolate Legionella colonies, providing high specificity and sensitivity. Culture can identify species and serogroups and support antimicrobial-susceptibility assessment.

Culture remains cost competitive and benefits from established laboratory expertise. Switching to alternatives requires training, equipment and validation.

PCR is the rapidly growing segment. It can return results in hours, detect small quantities of Legionella DNA and support faster outbreak control, risk mitigation and patient management. Real-time PCR reduces manual steps, while multiplex PCR can detect multiple Legionella species simultaneously. Regulatory acceptance of PCR as a culture alternative is supporting adoption.

Get Exclusive Sample Access: https://www.maximizemarketresearch.com/request-sample/228914/

Regional Growth Story

North America dominated the Legionella Testing Market in 2025 and is expected to retain its lead. Strict policies covering prevention and control across healthcare, hospitality, manufacturing and other industries support demand. The United States accounts for about 30% market share according to the report, while CDC and ASHRAE guidance supports Legionella-management practices.

Europe held about 30% share in 2025. Strict monitoring rules, awareness and ageing water infrastructure sustain testing demand, with Germany cited among countries with high reported case counts.

Asia Pacific held about 20% share in 2025 and is the fastest-growing region at an 8.7% CAGR. Urbanisation and infrastructure development in China and India are increasing risk in complex water systems, while rising healthcare expenditure and hospital-network expansion create opportunities. Japan and South Korea are covered, but separate market values are not published.

Competitive Landscape

Competition in the Legionella Testing Market centres on speed, accuracy, molecular diagnostics, distribution and environmental-testing reach. MMR identifies Quidel Corporation, Abbott, Merck KGaA, IDEXX Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Pall Corporation and Becton, Dickinson and Company among key participants.

R&D investment targets new technologies and broader portfolios. Mergers, acquisitions, product launches and joint ventures are also being used to widen customer reach.

Recent Developments

Recent activity in the Legionella Testing Market shows companies combining diagnostic scale with environmental-testing capabilities. Eurofins Scientific acquired Bio-Rad Clinical Diagnostics in February 2023, broadening its service portfolio and geographic reach. Mérieux NutriSciences acquired Silliker Laboratories in January 2023, strengthening environmental-testing capabilities including Legionella analysis.

Bio-Rad Laboratories partnered with Quidel Corporation in 2023 to expand access to Quidel’s point-of-care Legionella antigen test. Hygiena partnered with RKI-CERT GmbH in 2023 to focus on standardising and validating testing methods.

Get Exclusive Sample Access: https://www.maximizemarketresearch.com/request-sample/228914/

Strategic Implications

For healthcare providers, the Legionella Testing Market increasingly links respiratory diagnosis with environmental risk management. Hospitals and clinics need diagnostic capability, while facility operators must consider water-system monitoring as part of infection prevention. Laboratories face a portfolio choice between established culture and faster molecular techniques.

For investors and technology suppliers, PCR, automation, point-of-care testing, biosensors and digital platforms offer routes to differentiation. Suppliers that reduce complexity while preserving reliability can address a wider user base.

MMR does not provide quantified reimbursement trends or AI-diagnostics adoption statistics. It also does not publish country-level market values for the UK, Germany, China, Japan, India or South Korea.

Future Outlook

The Legionella Testing Market is moving toward faster, more connected and increasingly molecular testing. Ageing populations, waterborne-disease awareness, ageing infrastructure, urban development and stricter testing requirements support demand through 2032.

Digital platforms can improve process efficiency, point-of-care methods can expand access, and PCR can compress turnaround times. Asia Pacific provides the strongest regional growth signal, while North America remains the largest established market and Europe retains a strong regulatory foundation.

Access More Reports

Global ENT Devices Market 

Global Hormonal Contraceptives Market 

Global Surge Protection Devices Market 

Analyst Perspective  Komal Patil

The next phase will depend on whether suppliers can connect reliable detection with faster operational response. Microbial culture retains trust, specificity and established workflows, but PCR and other rapid technologies address the growing premium on speed.

Future winners will offer testing systems that fit clinical, environmental and water-management workflows while improving accessibility, validation and data handling.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.

Contact Us

2nd Floor, Navale IT Park Phase 3

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India

+91 9607365656

sales@maximizemarketresearch.com 

https://www.maximizemarketresearch.com